Literature DB >> 3886843

Characterization of membrane-bound aminopeptidases from rat brain: identification of the enkephalin-degrading aminopeptidase.

L B Hersh.   

Abstract

Rat brain aminopeptidase activity was solubilized from membranes by incubation with thiols. This novel procedure resulted in the release of the same two aminopeptidases (MI and MII) previously shown to be solubilized by the nonionic detergent Triton X-100. The solubilized aminopeptidases MI and MII were resolved by ion-exchange chromatography and further purified by hydroxylapatite chromatography. Aminopeptidase MI was shown to hydrolyze only the beta-naphthylamides of arginine and lysine whereas aminopeptidase MII exhibited a broad specificity with respect to amino acid beta-naphthylamides. Only aminopeptidase MII hydrolyzed Leu-enkephalin at a significant rate, indicating that this enzyme can account for the membrane-bound enkephalin aminopeptidase activity. The enkephalin-degrading aminopeptidase is potently inhibited by opioid (alpha-neo-endorphin and dynorphin) as well as nonopioid (substance P, somatostatin, and angiotensin I) peptides in the range of 0.2-2.0 microM. The regional distribution of aminopeptidases MI and MII in rat brain are rather different, with aminopeptidase MII distribution more closely paralleling the distribution of opiate receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886843     DOI: 10.1111/j.1471-4159.1985.tb08779.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.

Authors:  Bingbing Song; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

2.  Co2+-mediated time- and temperature-dependent activation of neutral alpha-D-mannosidase from monkey brain.

Authors:  R Mathur; K Panneerselvam; A S Balasubramanian
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

3.  Increased anxiety and impaired pain response in puromycin-sensitive aminopeptidase gene-deficient mice obtained by a mouse gene-trap method.

Authors:  T Osada; S Ikegami; K Takiguchi-Hayashi; Y Yamazaki; Y Katoh-Fukui; T Higashinakagawa; Y Sakaki; T Takeuchi
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

Review 4.  Tau-based treatment strategies in neurodegenerative diseases.

Authors:  Anja Schneider; Eckhard Mandelkow
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

5.  Proctolin degradation by membrane peptidases from nervous tissues of the desert locust (Schistocerca gregaria).

Authors:  R E Isaac
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

6.  Identification and characterization of aminopeptidases from Aplysia californica.

Authors:  W Bawab; E Querido; P Crine; L DesGroseillers
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

7.  Angiotensin II, dopamine and nitric oxide. An asymmetrical neurovisceral interaction between brain and plasma to regulate blood pressure.

Authors:  I Banegas; I Prieto; A B Segarra; M Martínez-Cañamero; M de Gasparo; M Ramírez-Sánchez
Journal:  AIMS Neurosci       Date:  2019-07-26

8.  Degradation of thymic humoral factor γ2 in human, rat and mouse blood: An experimental and theoretical study.

Authors:  Marcella Martignoni; Margherita Benedetti; Gavin P Davey; Keith F Tipton; Andrew G McDonald
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-06-05       Impact factor: 3.036

9.  Aminopeptidase activity in human nasal mucosa.

Authors:  K Ohkubo; J N Baraniuk; R Hohman; M Merida; L B Hersh; M A Kaliner
Journal:  J Allergy Clin Immunol       Date:  1998-11       Impact factor: 14.290

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.